Literature DB >> 3038243

Effects of phencyclidine, SKF 10,047 and related psychotomimetic agents on N-methyl-D-aspartate receptor mediated synaptic responses in rat hippocampal slices.

E J Coan, G L Collingridge.   

Abstract

The effects of representative drugs from three classes of psychotomimetic compounds (arylcyclohexylamines, benzomorphan opioids and dioxolanes) have been examined on synaptic transmission at an identified monosynaptic pathway in rat hippocampal slices. The compounds tested were phencyclidine (PCP) and ketamine, the racemate and isomers of SKF 10,047 (N-allylnormetazocine), and the isomers of dioxadrol (dexoxadrol and levoxadrol). In the absence of added magnesium ions (Mg) in the perfusion medium low frequency stimulation of the Schaffer collateral-commissural pathway evoked a burst of population spikes in the CA1 cell body region. The secondary components of this response could be abolished by the selective N-methyl-D-aspartate (NMDA) antagonist D-2-amino-5-phosphonovalerate (APV). PCP (1 microM) or ketamine (10 microM) selectively blocked the secondary components of the synaptic response. The effect of PCP was neither mimicked nor prevented by hexamethonium and atropine, phentolamine and propranolol, or clonidine and was therefore unlikely to involve cholinergic or adrenergic neurotransmitter systems. The sigma opiate, (+/-)-SKF 10,047 (10 microM) also abolished selectively the secondary components of the synaptic response. There was no apparent difference between the potency of the stereoisomers of this compound. The action of (+/-)-SKF 10,047 was not affected by either naloxone or haloperidol, indicating that this effect did not involve opioid receptors or the haloperidol-sensitive sigma site. Dexoxadrol (10 microM), but not levoxadrol (10 microM), also selectively blocked the secondary components of the synaptic response. It is concluded that these psychotomimetic agents can block an NMDA receptor-mediated component of synaptic transmission in the hippocampus and that this effect is mediated by a specific PCP/sigma site.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3038243      PMCID: PMC1853537          DOI: 10.1111/j.1476-5381.1987.tb11248.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  47 in total

1.  The pharmacology of 1-(1-phenylcyclohexyl) piperidine-HCl.

Authors:  G CHEN; C R ENSOR; D RUSSELL; B BOHNER
Journal:  J Pharmacol Exp Ther       Date:  1959-11       Impact factor: 4.030

2.  Demonstration of [3H]cyclazocine binding to multiple opiate receptor sites.

Authors:  R S Zukin; S R Zukin
Journal:  Mol Pharmacol       Date:  1981-09       Impact factor: 4.436

3.  Anticonvulsant action of excitatory amino acid antagonists.

Authors:  M J Croucher; J F Collins; B S Meldrum
Journal:  Science       Date:  1982-05-21       Impact factor: 47.728

4.  Multiple serotonin receptors: differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol.

Authors:  S J Peroutka; S H Snyder
Journal:  Mol Pharmacol       Date:  1979-11       Impact factor: 4.436

5.  Specific [3H]phencyclidine binding in rat central nervous system.

Authors:  S R Zukin; R S Zukin
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

6.  Evidence for sigma opioid receptor: binding of [3H]SKF-10047 to etorphine-inaccessible sites in guinea-pig brain.

Authors:  T P Su
Journal:  J Pharmacol Exp Ther       Date:  1982-11       Impact factor: 4.030

7.  Selective depression of excitatory amino acid induced depolarizations by magnesium ions in isolated spinal cord preparations.

Authors:  B Ault; R H Evans; A A Francis; D J Oakes; J C Watkins
Journal:  J Physiol       Date:  1980-10       Impact factor: 5.182

8.  Stereospecific binding of 3H-phencyclidine in brain membranes.

Authors:  R Y Hampton; F Medzihradsky; J H Woods; P J Dahlstrom
Journal:  Life Sci       Date:  1982-06-21       Impact factor: 5.037

9.  Pharmacological evaluation of N-allynormetazocine (SKF 10,047) on the basis of its discriminative stimulus properties in the rat.

Authors:  H E Shannon
Journal:  J Pharmacol Exp Ther       Date:  1983-04       Impact factor: 4.030

10.  Phencyclidine-like discriminative effects of opioids in the rat.

Authors:  S G Holtzman
Journal:  J Pharmacol Exp Ther       Date:  1980-09       Impact factor: 4.030

View more
  5 in total

1.  Action of anticonvulsants on hippocampal slices in Mg-free medium.

Authors:  C Psarropoulou; H L Haas
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-06       Impact factor: 3.000

2.  Effects of memantine and MK-801 on NMDA-induced currents in cultured neurones and on synaptic transmission and LTP in area CA1 of rat hippocampal slices.

Authors:  T Frankiewicz; B Potier; Z I Bashir; G L Collingridge; C G Parsons
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

3.  A low dose of the alpha2 agonist clonidine ameliorates the visual attention and spatial working memory deficits produced by phencyclidine administration to rats.

Authors:  J David Jentsch; Luigi A Anzivino
Journal:  Psychopharmacology (Berl)       Date:  2004-03-06       Impact factor: 4.530

4.  Clonidine and guanfacine attenuate phencyclidine-induced dopamine overflow in rat prefrontal cortex: mediating influence of the alpha-2A adrenoceptor subtype.

Authors:  J David Jentsch; Diana Sanchez; John D Elsworth; Robert H Roth
Journal:  Brain Res       Date:  2008-10-18       Impact factor: 3.252

5.  A Temporal Filter for Binaural Hearing Is Dynamically Adjusted by Sound Pressure Level.

Authors:  Ida Siveke; Andrea Lingner; Julian J Ammer; Sarah A Gleiss; Benedikt Grothe; Felix Felmy
Journal:  Front Neural Circuits       Date:  2019-02-13       Impact factor: 3.492

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.